Published 15 days ago

Pharmaceuticals: the sale of Biogaran reveals France’s inability to compete?

Summary by Le Parisien

Drug prices would be too low to be able to invest in French territory, warns pharmaceutical laboratories who want to put pressure on the government.

0 Articles

All

Left

Center

Right

Drug prices would be too low to be able to invest in French territory, warns pharmaceutical laboratories who want to put pressure on the government.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Total News Sources0

Leaning Left0Leaning Right1Center0Last Updated14 days agoBias Distribution

100% Right

100% Right

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)